2501
We report five cases of carboplatin ( CBDCA ) hypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2)/CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy .
 hypersensitivity, carboplatin; hypersensitivity, CBDCA; hypersensitivity, paclitaxel
Please list all entity pairs containing a certain relationship in the given options.Output format is "word1, word2; word3, word4". 
Option: adverse effect 
Text: {0} 
Answer:
 hypersensitivity, carboplatin; hypersensitivity, CBDCA; hypersensitivity, paclitaxel